• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

咖啡与肝细胞癌及慢性肝病风险:前瞻性研究的系统评价与荟萃分析

Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies.

作者信息

Bravi Francesca, Tavani Alessandra, Bosetti Cristina, Boffetta Paolo, La Vecchia Carlo

机构信息

aDepartment of Epidemiology, IRCCS-Istituto di Ricerche Farmacologiche Mario Negri bThe Tisch Cancer Institute and Institute of Translational Epidemiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA cDepartment of Clinical Sciences and Community Health, Università degli Studi di Milano, Milan, Italy.

出版信息

Eur J Cancer Prev. 2017 Sep;26(5):368-377. doi: 10.1097/CEJ.0000000000000252.

DOI:10.1097/CEJ.0000000000000252
PMID:27111112
Abstract

An inverse association has been reported between coffee drinking and the risk of hepatocellular carcinoma (HCC) and chronic liver disease (CLD), but its magnitude is still unclear. Thus, we carried out a systematic review and meta-analysis of prospective cohort studies that investigated the association between coffee consumption and the risk of HCC or CLD. We separately estimated the relative risk (RR) of the two conditions, for regular, low, and high consumption compared with no or occasional coffee consumption; we also calculated the summary RR for an increment of one cup of coffee per day. Twelve studies on HCC (3414 cases) and six studies on CLD (1463 cases) were identified. The summary RRs for HCC were 0.66 [95% confidence interval (CI): 0.55-0.78] for regular, 0.78 (95% CI: 0.66-0.91) for low, and 0.50 (95% CI: 0.43-0.58) for high coffee consumption, respectively. The summary RR for an increment of one cup per day was 0.85 (95% CI: 0.81-0.90). The summary RRs for CLD were 0.62 (95% CI: 0.47-0.82) for regular, 0.72 (95% CI: 0.59-0.88) for low, 0.35 (95% CI: 0.22-0.56) for high, and 0.74 (95% CI: 0.65-0.83) for an increment of one cup per day. The present meta-analysis provides a precise quantification of the inverse relation between coffee consumption and the risk of HCC, and adds evidence to the presence of an even stronger negative association with CLD.

摘要

据报道,咖啡饮用与肝细胞癌(HCC)和慢性肝病(CLD)风险之间存在负相关,但这种关联的程度仍不明确。因此,我们对调查咖啡消费与HCC或CLD风险之间关联的前瞻性队列研究进行了系统评价和荟萃分析。我们分别估计了经常、少量和大量饮用咖啡与不饮用或偶尔饮用咖啡相比,这两种疾病的相对风险(RR);我们还计算了每天增加一杯咖啡的汇总RR。共纳入了12项关于HCC的研究(3414例病例)和6项关于CLD的研究(1463例病例)。HCC的汇总RR分别为:经常饮用咖啡为0.66 [95%置信区间(CI):0.55 - 0.78],少量饮用为0.78(95% CI:0.66 - 0.91),大量饮用为0.50(95% CI:0.43 - 0.58)。每天增加一杯咖啡的汇总RR为0.85(95% CI:0.81 - 0.90)。CLD的汇总RR分别为:经常饮用咖啡为0.62(95% CI:0.47 - 0.82),少量饮用为0.72(95% CI:0.59 - 0.88),大量饮用为0.35(95% CI:0.22 - 0.56),每天增加一杯咖啡为0.74(95% CI:0.65 - 0.83)。本荟萃分析精确量化了咖啡消费与HCC风险之间的负相关关系,并进一步证明了与CLD存在更强的负相关关系。

相似文献

1
Coffee and the risk of hepatocellular carcinoma and chronic liver disease: a systematic review and meta-analysis of prospective studies.咖啡与肝细胞癌及慢性肝病风险:前瞻性研究的系统评价与荟萃分析
Eur J Cancer Prev. 2017 Sep;26(5):368-377. doi: 10.1097/CEJ.0000000000000252.
2
Coffee, including caffeinated and decaffeinated coffee, and the risk of hepatocellular carcinoma: a systematic review and dose-response meta-analysis.咖啡,包括含咖啡因咖啡和脱咖啡因咖啡,与肝细胞癌风险:一项系统评价和剂量反应荟萃分析
BMJ Open. 2017 May 9;7(5):e013739. doi: 10.1136/bmjopen-2016-013739.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
4
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
5
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
6
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
7
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD010216. doi: 10.1002/14651858.CD010216.pub7.
8
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2021 Sep 14;9(9):CD010216. doi: 10.1002/14651858.CD010216.pub6.
9
Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis.成人全身麻醉后预防术后恶心呕吐的药物:网状Meta分析
Cochrane Database Syst Rev. 2020 Oct 19;10(10):CD012859. doi: 10.1002/14651858.CD012859.pub2.
10
Electronic cigarettes for smoking cessation.电子烟戒烟。
Cochrane Database Syst Rev. 2024 Jan 8;1(1):CD010216. doi: 10.1002/14651858.CD010216.pub8.

引用本文的文献

1
Mendelian randomization identifies genetically predicted calorie dietary preference as causal risk factors for cancer.孟德尔随机化研究将基因预测的卡路里饮食偏好确定为癌症的因果风险因素。
Discov Oncol. 2025 Aug 18;16(1):1582. doi: 10.1007/s12672-025-03213-8.
2
Assessing the genetic estimates of the association between plasma caffeine and cancer risk through Mendelian randomization.通过孟德尔随机化评估血浆咖啡因与癌症风险之间关联的遗传估计值。
Eur J Nutr. 2025 Apr 5;64(4):145. doi: 10.1007/s00394-025-03663-4.
3
Risk factors for hepatocellular carcinoma: an umbrella review of systematic review and meta-analysis.
肝细胞癌的危险因素:系统评价与荟萃分析的伞状综述
Ann Med. 2025 Dec;57(1):2455539. doi: 10.1080/07853890.2025.2455539. Epub 2025 Jan 20.
4
Digestive cancers: mechanisms, therapeutics and management.消化系统癌症:机制、治疗方法与管理
Signal Transduct Target Ther. 2025 Jan 15;10(1):24. doi: 10.1038/s41392-024-02097-4.
5
Caffeine: A Multifunctional Efficacious Molecule with Diverse Health Implications and Emerging Delivery Systems.咖啡因:一种具有多种功效的多功能有效分子,具有多种健康影响和新兴的输送系统。
Int J Mol Sci. 2024 Nov 8;25(22):12003. doi: 10.3390/ijms252212003.
6
Cancers attributable to diet in Italy.意大利因饮食导致的癌症。
Int J Cancer. 2025 Mar 15;156(6):1181-1190. doi: 10.1002/ijc.35227. Epub 2024 Oct 24.
7
Hepatocellular Carcinoma: Surgical Management and Evolving Therapies.肝细胞癌:手术治疗与不断发展的治疗策略。
Cancer Treat Res. 2024;192:185-206. doi: 10.1007/978-3-031-61238-1_10.
8
Treatment Options and Continuity of Care in Metabolic-associated Fatty Liver Disease: A Multidisciplinary Approach.代谢相关脂肪性肝病的治疗选择与照护连续性:多学科方法
Eur Cardiol. 2024 Jun 19;19:e06. doi: 10.15420/ecr.2023.34. eCollection 2024.
9
Kahweol Inhibits Pro-Inflammatory Cytokines and Chemokines in Tumor Necrosis Factor-α/Interferon-γ-Stimulated Human Keratinocyte HaCaT Cells.咖啡豆醇抑制肿瘤坏死因子-α/干扰素-γ刺激的人角质形成细胞HaCaT细胞中促炎细胞因子和趋化因子的产生。
Curr Issues Mol Biol. 2024 Apr 18;46(4):3470-3483. doi: 10.3390/cimb46040218.
10
Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy.全球肝细胞癌流行病学趋势:对筛查、预防和治疗的启示。
Nat Rev Clin Oncol. 2023 Dec;20(12):864-884. doi: 10.1038/s41571-023-00825-3. Epub 2023 Oct 26.